Erli Tab. 10mg CP 2X7's
Generic Name: Empagliflozin
Therapeutic Segment: Anti-diabetic
Indication:
- Glycemic control in Diabetes Mellitus Type II, risk of cardiovascular death in adult patient with Diabetes Mellitus Type II.
Available as: Tablets
Strength: 10 mg, 25 mg
DESCRIPTION
Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, lowers the renal threshold for glucose and increases urinary glucose excretion by interfering with the reabsorption of renally-filtered glucose across the tubular lumen of the proximal renal tubules. Empagliflozin decreases fasting and post-prandial blood glucose levels, and imparts a low risk of hypoglycemia as its mechanism of action is independent of beta cell function and insulin pathway
PRESENTATION
Erli 10mg : Pack of 14 Tablets
Erli 25mg : Pack of 14 Tablets
INSTRUCTIONS Use as advised by the physician. Keep all medicines out of the reach of children. To be sold on the prescription of a registered medical practitioner only. Protect from light, heat and moisture. Store below 30°C.